Literature DB >> 34052362

Investigating whether a combination of higher CRP and depression is differentially associated with worse executive functioning in a cohort of 43,896 adults.

Naoise Mac Giollabhui1, Lauren B Alloy2, Lizanne J S Schweren3, Catharina A Hartman4.   

Abstract

Many depressed individuals experience difficulties in executive functioning that contribute substantially to functional impairment. It is unknown whether a subtype of depression characterized by chronic inflammation is differentially associated with worse executive functioning. This study examined whether the combination of depression and higher C reactive protein (CRP) is differentially associated with worse executive functioning and whether this association is stronger in older adults. This cross-sectional study analyzed data collected from a population-representative sample of 43,896 adults aged 44.13 years (SD = 13.52) who participated in the baseline assessment of the Lifelines cohort study. Multivariate regression models tested whether depressed individuals (established via structured interview) exhibiting higher levels of inflammation (indexed via high-sensitivity CRP assay following an overnight fast) performed worse on a behavioral test of executive functioning. Depression (B = -3.66, 95% CI: -4.82, -2.49, p < .001) and higher log-transformed CRP (B = -0.67, 95% CI: -0.87,-0.47, p < .001) were associated with worse executive functioning, after adjustment for age, sex, educational attainment, body mass index, smoking status, exposure to stressful life events and chronic stressors, sedentary behavior, and number of chronic medical conditions. Depressed individuals with higher log-transformed CRP exhibited differentially poorer executive functioning (B = -1.09, 95% CI: -2.07,-0.11, p < .001). This association did not differ based on age (B = 0.01, 95% CI: -0.08, 0.10, p = .82). Executive functioning is poorer in depressed individuals with higher CRP, even in early adulthood. Interventions that reduce inflammation may improve cognitive functioning in depression.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Cognition; Depression; Executive functioning; Inflammation

Mesh:

Substances:

Year:  2021        PMID: 34052362      PMCID: PMC8319077          DOI: 10.1016/j.bbi.2021.05.022

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   19.227


  70 in total

1.  Cognitive function following a major depressive episode: a systematic review and meta-analysis.

Authors:  Maria Semkovska; Lisa Quinlivan; Tara O'Grady; Rebecca Johnson; Aisling Collins; Jessica O'Connor; Hannah Knittle; Elayne Ahern; Taylor Gload
Journal:  Lancet Psychiatry       Date:  2019-08-15       Impact factor: 27.083

2.  The reliability and convergent and divergent validity of the Ruff Figural Fluency Test in healthy young adults.

Authors:  Thomas P Ross
Journal:  Arch Clin Neuropsychol       Date:  2014-10-14       Impact factor: 2.813

Review 3.  A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder.

Authors:  Rico S C Lee; Daniel F Hermens; Melanie A Porter; M Antoinette Redoblado-Hodge
Journal:  J Affect Disord       Date:  2011-11-15       Impact factor: 4.839

4.  Cytokine-associated emotional and cognitive disturbances in humans.

Authors:  A Reichenberg; R Yirmiya; A Schuld; T Kraus; M Haack; A Morag; T Pollmächer
Journal:  Arch Gen Psychiatry       Date:  2001-05

5.  Executive dysfunction in depression in adolescence: the role of inflammation and higher body mass.

Authors:  Naoise Mac Giollabhui; Dominika Swistun; Susan Murray; Daniel P Moriarity; Marin M Kautz; Lauren M Ellman; Thomas M Olino; Christopher L Coe; Lyn Y Abramson; Lauren B Alloy
Journal:  Psychol Med       Date:  2019-03-28       Impact factor: 7.723

6.  Generation of stress in the course of unipolar depression.

Authors:  C Hammen
Journal:  J Abnorm Psychol       Date:  1991-11

7.  The macrophage theory of depression.

Authors:  R S Smith
Journal:  Med Hypotheses       Date:  1991-08       Impact factor: 1.538

8.  Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.

Authors:  Michael T Treadway; Michael L Waskom; Daniel G Dillon; Avram J Holmes; Min Tae M Park; M Mallar Chakravarty; Sunny J Dutra; Frida E Polli; Dan V Iosifescu; Maurizio Fava; John D E Gabrieli; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2014-07-03       Impact factor: 13.382

9.  Early postoperative systemic inflammatory response is an important determinant for adverse 2-year neurodevelopment-associated outcomes after the Norwood procedure.

Authors:  Xiaohui Li; Charlene M T Robertson; Xiaoyang Yu; Andriy Cheypesh; Irina A Dinu; Jia Li
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-20       Impact factor: 5.209

Review 10.  Cognitive impairment in depression: a systematic review and meta-analysis.

Authors:  P L Rock; J P Roiser; W J Riedel; A D Blackwell
Journal:  Psychol Med       Date:  2013-10-29       Impact factor: 7.723

View more
  3 in total

1.  Stabilometric Biofeedback Training in Cognitive and Affective Function Improvement. Contribution of the Russian Scientific School. Part II.

Authors:  O M Bazanova; A V Kovaleva
Journal:  Hum Physiol       Date:  2022-06-03

2.  Association between depression symptoms and moderately increased levels of the inflammation marker albuminuria is explained by age and comorbidity.

Authors:  Solfrid Romundstad; Torfinn Hynnekleiv
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

Review 3.  C-Reactive Protein as a Biomarker for Major Depressive Disorder?

Authors:  Laura Orsolini; Simone Pompili; Silvia Tempia Valenta; Virginio Salvi; Umberto Volpe
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.